MRC1 and neoplasm: St-PGA-DOX-mUNO (referred to as OximUNO) efficiently depleted CD206+ TAMs, relieved immunosuppression in the tumor microenvironment (TME) and limited metastasis/tumor growth, thereby supporting OximUNO as an alternative TAM depletion strategy.